Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.
1. Introduction - p. xxiii 2. Section I: Nanomedicines in drug delivery - p. S1 3. 1. Clinical uses of inorganic and organic nanoparticles in metabolic syndromes - p. 3 4. 2. Application of nanomedicines in mitigating oxidative stress - p. 25 5. 3. Nanomedicines to enhance oral bioavailability for metabolic disorders - p. 63 6. 4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders - p. 79 7. Section II: Nanotechnology in metabolic disorders: diagnosis and therapy - p. S99 8. 5. Application of quantum dots in metabolic disorders - p. 101 9. 6. Medical imaging using nanotechnology - p. 129 10. 7. Nanorobotics: applications in metabolic disorders - p. 163 11. 8. Nanomaterials for three-dimensional printing in management of metabolic disorders - p. 189 12. Section III: Nanomedicines for lifestyle metabolic disorders - p. S225 13. 9. Nanomedicines to alleviate hepatic metabolic disorders - p. 227 14. 10. Role of nanomedicines in type 2 diabetes - p. 269 15. 11. Nanomedicines for precise therapy in hyperlipidemia and obesity - p. 305 16. Section IV: Nanomedicines in genetic regulation for cellular metabolic disorders - p. S375 17. 12. Application of nanotechnology in lysosomal storage diseases - p. 377 18. 13. Nanotechnology to target autophagy-mediated metabolic disorders - p. 421 19. 14. Application of nanomedicine in glycogen storage diseases - p. 475 20. Section V: Nanomedicines for metabolic cardiovascular diseases - p. S487 21. 15. Nanotechnology for metabolic vascular diseases - p. 489 22. 16. Nanomedicines for the management of atherosclerosis - p. 515 23. Author Index - p. 553 24. Subject Index - p. 555
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.
1. Introduction - p. xxiii 2. Section I: Nanomedicines in drug delivery - p. S1 3. 1. Clinical uses of inorganic and organic nanoparticles in metabolic syndromes - p. 3 4. 2. Application of nanomedicines in mitigating oxidative stress - p. 25 5. 3. Nanomedicines to enhance oral bioavailability for metabolic disorders - p. 63 6. 4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders - p. 79 7. Section II: Nanotechnology in metabolic disorders: diagnosis and therapy - p. S99 8. 5. Application of quantum dots in metabolic disorders - p. 101 9. 6. Medical imaging using nanotechnology - p. 129 10. 7. Nanorobotics: applications in metabolic disorders - p. 163 11. 8. Nanomaterials for three-dimensional printing in management of metabolic disorders - p. 189 12. Section III: Nanomedicines for lifestyle metabolic disorders - p. S225 13. 9. Nanomedicines to alleviate hepatic metabolic disorders - p. 227 14. 10. Role of nanomedicines in type 2 diabetes - p. 269 15. 11. Nanomedicines for precise therapy in hyperlipidemia and obesity - p. 305 16. Section IV: Nanomedicines in genetic regulation for cellular metabolic disorders - p. S375 17. 12. Application of nanotechnology in lysosomal storage diseases - p. 377 18. 13. Nanotechnology to target autophagy-mediated metabolic disorders - p. 421 19. 14. Application of nanomedicine in glycogen storage diseases - p. 475 20. Section V: Nanomedicines for metabolic cardiovascular diseases - p. S487 21. 15. Nanotechnology for metabolic vascular diseases - p. 489 22. 16. Nanomedicines for the management of atherosclerosis - p. 515 23. Author Index - p. 553 24. Subject Index - p. 555
